1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New York >
  6. Chiral Technologies Acquires Diffinity Genomics

M&A Deal Summary

Chiral Technologies Acquires Diffinity Genomics

On August 4, 2015, Chiral Technologies acquired life science company Diffinity Genomics

Acquisition Highlights
  • This is Chiral Technologies’ 1st transaction in the Life Science sector.
  • This is Chiral Technologies’ 1st transaction in the United States.
  • This is Chiral Technologies’ 1st transaction in New York.

M&A Deal Summary
Date 2015-08-04
Target Diffinity Genomics
Sector Life Science
Buyer(s) Chiral Technologies
Deal Type Add-on Acquisition

Target

Diffinity Genomics

West Henrietta, New York, United States
Diffinity Genomics, Inc. is a life science company with technologies that enable the development of single-use disposable products for medical, industrial and research applications in DNA purification markets.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Chiral Technologies

West Chester, Pennsylvania, United States
Category Company
Founded 1990
Sector Information Technology
DESCRIPTION

Chiral Technologies, Inc. is an enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal